Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Cash flow is valuable, but it’s not everything - StockStory helps you identify the companies that truly put it to work. That said, here are three cash-producing companies to avoid and some better opportunities instead.
DocuSign (DOCU)
Trailing 12-Month Free Cash Flow Margin: 34.1%
Creating the digital equivalent of "sign on the dotted line" for over a billion users worldwide, DocuSign (NASDAQ: DOCU) provides an agreement management platform that enables businesses to electronically prepare, sign, and manage documents and contracts.
Why Do We Think DOCU Will Underperform?
- Customers were hesitant to make long-term commitments to its software as its 8.5% average ARR growth over the last year was sluggish
- Competitive market means the company must spend more on sales and marketing to stand out even if the return on investment is low
- Operating margin improvement of 2.8 percentage points over the last year demonstrates its ability to scale efficiently
DocuSign’s stock price of $45.87 implies a valuation ratio of 2.5x forward price-to-sales. Dive into our free research report to see why there are better opportunities than DOCU.
Landstar (LSTR)
Trailing 12-Month Free Cash Flow Margin: 4.7%
Covering billions of miles throughout North America, Landstar (NASDAQ: LSTR) is a transportation company specializing in freight and last-mile delivery services.
Why Should You Sell LSTR?
- Customers postponed purchases of its products and services this cycle as its revenue declined by 2.8% annually over the last two years
- Performance over the past five years shows its incremental sales were much less profitable, as its earnings per share fell by 8.1% annually
- Waning returns on capital imply its previous profit engines are losing steam
Landstar is trading at $208.20 per share, or 34.8x forward P/E. If you’re considering LSTR for your portfolio, see our FREE research report to learn more.
Privia Health (PRVA)
Trailing 12-Month Free Cash Flow Margin: 6.1%
Operating in 13 states and the District of Columbia with over 4,300 providers serving more than 4.8 million patients, Privia Health (NASDAQ: PRVA) is a technology-driven company that helps physicians optimize their practices, improve patient experiences, and transition to value-based care models.
Why Does PRVA Give Us Pause?
- Subscale operations are evident in its revenue base of $2.25 billion, meaning it has fewer distribution channels than its larger rivals
- Low free cash flow margin of 5% for the last five years gives it little breathing room, constraining its ability to self-fund growth or return capital to shareholders
- Low returns on capital reflect management’s struggle to allocate funds effectively
At $27.35 per share, Privia Health trades at 24.9x forward P/E. Read our free research report to see why you should think twice about including PRVA in your portfolio.
Stocks We Like More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
